...
机译:晚期内体衔接子分子P14(Lamtor2)代表Langerhans细胞稳态的新型调节剂
Department of Dermatology and Venereology Innsbruck Medical University Anichstrasse 35 A-6020;
Division of Cell Biology Bio Center Innsbruck Austria;
Institute for Cancer Research Medical University of Vienna Vienna Austria;
Department of Dermatology and Venereology Innsbruck Medical University Anichstrasse 35 A-6020;
Department of Dermatology and Venereology Innsbruck Medical University Anichstrasse 35 A-6020;
Department of Anesthesiology and Critical Care Medicine Innsbruck Medical University Innsbruck;
Department of Immunology Erasmus University Medical Center Rotterdam Netherlands;
Department of Immunology Erasmus University Medical Center Rotterdam Netherlands Institute for;
Department of Microbiology and Immunology Columbia University Medical Center New York NY United;
Institute for Cancer Research Medical University of Vienna Vienna Austria;
Department of Dermatology and Venereology Innsbruck Medical University Anichstrasse 35 A-6020;
Department of Dermatology and Venereology Innsbruck Medical University Anichstrasse 35 A-6020;
机译:晚期内体衔接子分子p14(LAMTOR2)代表了朗格汉斯细胞稳态的新型调节剂
机译:晚期内体衔接子分子P14(Lamtor2)代表Langerhans细胞稳态的新型调节剂
机译:晚期内体衔接分子p14(LAMTOR2)调节TGFβ1介导的Langerhans细胞稳态。
机译:朗格罕岛的胰岛是葡萄糖稳态的主要调节剂
机译:树突状细胞的动态平衡和迁移:解读MAP激酶激活在朗格汉斯细胞组织增生症中的作用
机译:晚期内体衔接子分子p14(LAMTOR2)代表了Langerhans细胞稳态的新型调节剂
机译:内体晚期衔接子分子p14(LAMTOR2)代表了朗格汉斯细胞稳态的新型调节剂